TVCI launches clinical grading scale app

Article

The Vision Care Institute recently launched an app for clinical grading scales, designed to help practitioners assess the severity and evaluate the progression of complications associated with contact lens wear.

Jacksonville, FL-The Vision Care Institute recently launched its Clinical Grading Scales App, an educational tool designed to help practitioners assess the severity and evaluate the progression of complications associated with contact lens wear.

Based on the clinical assessment guide derived from the grading scales developed by Prof. Nathan Efron of Queensland University of Technology, Brisbane, Australia, eyecare professionals can use this resource during patient evaluations and follow-up.

The new app allows users to:

· Evaluate 9 common eye conditions (bulbar redness, corneal staining, lid redness, lid roughness, limbal redness, meibomian gland dysfunction, pterygium, pinguecula, cortical cataract) with severity levels that lessen and increase with real-time animation based on touch.

· Evaluate the progression of complications by comparing severity levels in small increments side-by-side.

· Demonstrate clinical assessment to patients.

· Export a report for office records without collecting personal data.

· View a comprehensive assessment guide including slit lamp illumination techniques, corneal inflammation vs. infection, signs of oxygen deficiency, staining and lid assessments, and more.

 

The Vision Care Institute Clinical Grading Scales is a free app, compatible with the iPhone, and can be downloaded via the Apple App Store. It is not intended as, and does not constitute medical or optometric advice. At this time, it is available only in the U.S. App Store. 

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Karl Stonecipher ASCRS 2025
AnnMarie Hipsley, DPT, PhD, at ASCRS 2025
Neda Shamie, MD; Selina McGee, OD, FAAO, Dipl ABO; and Jacob Lang, OD, FAAO; provided their insights during CIME 2025 on May 4.
At ARVO 2025, Mark Bullimore, MCOptom, PhD, emphasized the need for more accurate, condition-specific tools in evaluating myopic eye growth and treatment efficacy.
Dr Luke Lindsell discusses retinal therapy and geographic atrophy at Controversies in Modern Eye Care 2025
Neda Shamie, MD, speaks on cataract and refractive surgery at CIME 2025.
Dr Selina McGee shares thoughts on pharmacological presbyopia correction at Controversies in Modern Eye Care 2025
Paul Hammond, OD, FAAO, presents a poster at ARVO 2025 on the creation of a conversion factor between 2 OCT devices to monitor glaucoma progression
What to know about legislative moves that have been made through May this year.
© 2025 MJH Life Sciences

All rights reserved.